| Aurobindo Pharma Limited | 1,252 | 1,252G/0B | $0.5908 | +0.41% | 560↑ 462↓of 1022 | 2 | 17 |
| Sun Pharmaceutical Industries Inc. | 933 | 904G/29B | $2.9735 | +0.44% | 272↑ 229↓of 501 | 9 | 18 |
| NorthStar Rx LLC | 899 | 899G/0B | $1.5561 | +1.02% | 441↑ 370↓of 811 | 1 | 6 |
| Teva Pharmaceuticals USA Inc. | 812 | 795G/17B | $67.1066 | -0.11% | 334↑ 397↓of 731 | 6 | 13 |
| Rising Pharma Holdings Inc. | 764 | 763G/1B | $0.6951 | +0.81% | 386↑ 323↓of 709 | 1 | 7 |
| Major Pharmaceuticals | 734 | 734G/0B | $0.2666 | +0.55% | 351↑ 314↓of 665 | 24 | 7 |
| Dr. Reddy's Laboratories Inc. | 701 | 701G/0B | $2.1292 | +0.30% | 276↑ 262↓of 538 | 3 | 8 |
| Camber Pharmaceuticals Inc. | 668 | 668G/0B | $1.2055 | +0.73% | 370↑ 236↓of 606 | 1 | 7 |
| American Health Packaging | 639 | 638G/1B | $0.3474 | +0.86% | 342↑ 264↓of 606 | 34 | 3 |
| Mylan Pharmaceuticals Inc. | 628 | 623G/5B | $2.5463 | +0.18% | 278↑ 257↓of 535 | 9 | 9 |
| Zydus Pharmaceuticals (USA) Inc. | 625 | 618G/7B | $1.5117 | +1.23% | 294↑ 250↓of 544 | 2 | 9 |
| Lupin Pharmaceuticals Inc. | 557 | 552G/5B | $5.0992 | +0.81% | 258↑ 161↓of 419 | 2 | 13 |
| Alembic Pharmaceuticals Inc. | 523 | 523G/0B | $0.9499 | +1.16% | 296↑ 203↓of 499 | 2 | 2 |
| Chartwell RX LLC | 521 | 521G/0B | $0.5348 | +1.22% | 256↑ 224↓of 480 | 5 | 10 |
| Ascend Laboratories, LLC | 461 | 461G/0B | $1.1085 | +0.32% | 226↑ 177↓of 403 | — | 5 |
| Glenmark Pharmaceuticals Inc., USA | 444 | 444G/0B | $1.5674 | +0.88% | 200↑ 147↓of 347 | 1 | 8 |
| Actavis Pharma, Inc. | 439 | 438G/1B | $1.0309 | +0.60% | 193↑ 167↓of 360 | 3 | 9 |
| Strategic Sourcing Services LLC | 431 | 431G/0B | $0.2693 | -0.35% | 118↑ 159↓of 277 | 2 | 3 |
| Cardinal Health | 420 | 420G/0B | $0.1986 | -0.33% | 138↑ 174↓of 312 | 4 | 2 |
| Macleods Pharmaceuticals Limited | 418 | 418G/0B | $0.4462 | +1.11% | 222↑ 144↓of 366 | — | — |
| Hikma Pharmaceuticals USA Inc. | 414 | 414G/0B | $2.5718 | -0.01% | 158↑ 151↓of 309 | 2 | 3 |
| BluePoint Laboratories | 395 | 395G/0B | $2.8364 | +1.58% | 197↑ 133↓of 330 | 1 | 2 |
| Sandoz Inc. | 394 | 351G/43B | $22.1484 | -0.29% | 150↑ 152↓of 302 | 3 | 10 |
| AmerisourceBergen | 393 | 393G/0B | $0.3000 | -0.29% | 150↑ 175↓of 325 | — | 2 |
| Amneal Pharmaceuticals LLC | 388 | 359G/29B | $4.3482 | +0.80% | 153↑ 97↓of 250 | 2 | 15 |
| Solco Healthcare US LLC | 365 | 365G/0B | $0.2237 | +0.68% | 189↑ 160↓of 349 | 1 | 2 |
| Apotex Corp. | 362 | 350G/12B | $4.9887 | +0.12% | 155↑ 152↓of 307 | 2 | 9 |
| Heritage Pharmaceuticals Inc. | 317 | 317G/0B | $0.4696 | +0.70% | 155↑ 131↓of 286 | 2 | 7 |
| Accord Healthcare Inc. | 316 | 316G/0B | $0.6836 | +0.72% | 53↑ 32↓of 85 | 2 | 12 |
| Torrent Pharmaceuticals Limited | 315 | 315G/0B | $1.9075 | +0.40% | 143↑ 121↓of 264 | — | 2 |
| Cipla USA Inc. | 308 | 308G/0B | $1.4241 | -0.01% | 97↑ 105↓of 202 | — | 7 |
| Unichem Pharmaceuticals (USA) Inc. | 306 | 306G/0B | $0.1344 | +0.57% | 137↑ 141↓of 278 | — | 3 |
| Amneal Pharmaceuticals NY LLC | 306 | 306G/0B | $3.3349 | +1.16% | 139↑ 122↓of 261 | — | 8 |
| Upsher-Smith Laboratories LLC | 305 | 263G/42B | $3.1519 | +1.65% | 123↑ 91↓of 214 | 2 | 12 |
| AvPAK | 300 | 300G/0B | $0.2213 | +1.11% | 159↑ 120↓of 279 | 7 | 1 |
| ANI Pharmaceuticals, Inc. | 296 | 279G/17B | $3.0531 | +0.83% | 139↑ 129↓of 268 | 3 | 12 |
| Exelan Pharmaceuticals Inc. | 285 | 285G/0B | $0.2244 | +0.31% | 138↑ 121↓of 259 | — | — |
| Advagen Pharma Ltd. | 278 | 278G/0B | $0.3862 | +0.15% | 140↑ 138↓of 278 | — | 3 |
| Amneal Pharmaceuticals of New York LLC | 263 | 263G/0B | $3.1064 | +0.30% | 75↑ 74↓of 149 | — | 7 |
| Westminster Pharmaceuticals LLC | 263 | 263G/0B | $0.2573 | +0.48% | 136↑ 109↓of 245 | 1 | 1 |
| Padagis Israel Pharmaceuticals Ltd | 261 | 259G/2B | $3.2570 | +0.70% | 121↑ 122↓of 243 | — | 10 |
| Lannett Company Inc. | 258 | 258G/0B | $0.8126 | +1.77% | 129↑ 71↓of 200 | — | 6 |
| Strides Pharma Inc. | 247 | 247G/0B | $0.4121 | -0.24% | 104↑ 109↓of 213 | 1 | 3 |
| Epic Pharma LLC | 243 | 243G/0B | $0.4285 | +1.48% | 71↑ 48↓of 119 | 1 | 1 |
| Chain Drug Marketing Association | 227 | 227G/0B | $0.1216 | -0.46% | 56↑ 66↓of 122 | 3 | 3 |
| Endo USA Inc. | 219 | 204G/15B | $7.3531 | +1.29% | 111↑ 81↓of 192 | — | 8 |
| Granules Pharmaceuticals Inc. | 209 | 209G/0B | $0.5729 | +1.19% | 122↑ 75↓of 197 | — | 1 |
| Rugby Laboratories | 209 | 209G/0B | $0.4416 | +0.22% | 104↑ 84↓of 188 | 1 | 3 |
| Haleon US Holdings LLC | 203 | 0G/203B | $0.5315 | — | — | — | 8 |
| Ajanta Pharma USA Inc. | 194 | 194G/0B | $0.8005 | +2.06% | 101↑ 58↓of 159 | — | 5 |
| Novadoz Pharmaceuticals LLC | 191 | 191G/0B | $2.5516 | +0.07% | 95↑ 84↓of 179 | 3 | 2 |
| SpecGx LLC | 173 | 168G/5B | $1.6877 | -0.33% | 65↑ 92↓of 157 | — | 2 |
| L. Perrigo Company | 167 | 161G/6B | $0.2666 | -0.27% | 65↑ 91↓of 156 | — | 1 |
| Fresenius Kabi USA, LLC | 165 | 157G/8B | $24.4910 | +1.35% | 45↑ 40↓of 85 | — | 2 |
| Mylan Institutional LLC | 149 | 147G/2B | $25.1903 | -0.48% | 54↑ 60↓of 114 | 6 | — |
| Lifestar Pharma LLC | 148 | 148G/0B | $0.9022 | +1.35% | 61↑ 65↓of 126 | 2 | 1 |
| Quallent Pharmaceuticals Health LLC | 147 | 147G/0B | $4.5389 | +0.32% | 73↑ 72↓of 145 | 1 | 1 |
| Allergan, Inc. | 146 | 0G/146B | $40.6075 | -0.12% | 31↑ 53↓of 84 | — | 18 |
| Ingenus Pharmaceuticals LLC | 144 | 141G/3B | $3.6457 | +0.06% | 62↑ 63↓of 125 | 1 | 4 |
| Nivagen Pharmaceuticals Inc. | 137 | 137G/0B | $0.8421 | +0.60% | 33↑ 30↓of 63 | 2 | 5 |
| Viona Pharmaceuticals Inc. | 133 | 133G/0B | $0.4800 | +0.54% | 73↑ 58↓of 131 | — | 2 |
| Bionpharma Inc. | 131 | 131G/0B | $0.5737 | -0.47% | 56↑ 67↓of 123 | 3 | 1 |
| KVK-Tech Inc. | 130 | 130G/0B | $0.5267 | -0.86% | 30↑ 57↓of 87 | — | 4 |
| Cosette Pharmaceuticals, Inc. | 128 | 108G/20B | $4.1936 | +0.04% | 59↑ 49↓of 108 | — | 6 |
| Leading Pharma, LLC | 125 | 125G/0B | $0.8568 | -0.30% | 55↑ 47↓of 102 | 1 | 3 |
| ScieGen Pharmaceuticals, Inc. | 122 | 122G/0B | $0.0969 | -0.36% | 60↑ 59↓of 119 | — | 1 |
| Micro Labs Limited | 120 | 120G/0B | $0.6418 | +0.23% | 44↑ 48↓of 92 | 1 | 2 |
| Hospira Inc. | 119 | 117G/2B | $4.2857 | +0.89% | 29↑ 14↓of 43 | 2 | 3 |
| Jubilant Cadista Pharmaceuticals Inc. | 119 | 119G/0B | $0.2396 | +0.84% | 29↑ 33↓of 62 | — | 3 |
| Pfizer Inc. | 118 | 0G/118B | $62.7740 | -0.25% | 21↑ 21↓of 42 | — | 19 |
| RB Health (US) LLC | 110 | 0G/110B | $0.4154 | — | — | — | 5 |
| Method Pharmaceuticals LLC | 110 | 110G/0B | $0.2685 | +0.25% | 51↑ 43↓of 94 | — | 1 |
| Oceanside Pharmaceuticals | 108 | 108G/0B | $10.9894 | — | — | — | 4 |
| Bausch Health US LLC | 104 | 3G/101B | $34.0775 | — | — | — | 19 |
| Prasco Laboratories | 103 | 103G/0B | $14.0622 | +0.15% | 45↑ 47↓of 92 | 1 | 1 |
| Aurolife Pharma LLC | 99 | 99G/0B | $0.2399 | -0.45% | 38↑ 53↓of 91 | — | — |
| Taro Pharmaceuticals U.S.A. Inc. | 98 | 97G/1B | $0.8351 | +4.20% | 36↑ 28↓of 64 | — | 1 |
| Rhodes Pharmaceuticals L.P. | 97 | 83G/14B | $4.0135 | -0.23% | 28↑ 42↓of 70 | 1 | 1 |
| Viatris Specialty LLC | 95 | 3G/92B | $26.2230 | -0.07% | 24↑ 40↓of 64 | — | 21 |
| Slate Run Pharmaceuticals LLC | 94 | 94G/0B | $1.3446 | +3.09% | 27↑ 9↓of 36 | — | 2 |
| Alvogen Inc. | 94 | 94G/0B | $13.7268 | -0.05% | 40↑ 36↓of 76 | — | 2 |
| TruPharma LLC | 94 | 94G/0B | $0.9701 | -0.20% | 39↑ 41↓of 80 | — | 6 |
| Somerset Therapeutics, LLC | 93 | 93G/0B | $5.0964 | -0.49% | 41↑ 44↓of 85 | 1 | 2 |
| Biocon Pharma Inc. | 93 | 93G/0B | $2.3831 | -0.54% | 34↑ 53↓of 87 | — | 1 |
| Novartis Pharmaceuticals Corporation | 92 | 0G/92B | $767.89 | — | 19↑ 13↓of 32 | — | 15 |
| ScieGen Pharmaceuticals Inc. | 91 | 91G/0B | $0.2109 | -0.24% | 44↑ 45↓of 89 | — | — |
| Merck Sharp & Dohme LLC | 89 | 0G/89B | $84.8759 | -0.01% | 16↑ 31↓of 47 | — | 5 |
| Encube Ethicals, Inc. | 88 | 88G/0B | $0.8231 | +0.95% | 48↑ 37↓of 85 | — | — |
| AbbVie Inc. | 88 | 1G/87B | $1245.74 | -0.02% | 13↑ 44↓of 57 | — | 5 |
| Xiromed LLC | 88 | 88G/0B | $3.4809 | +1.68% | 56↑ 28↓of 84 | — | — |
| Time-Cap Labs Inc. | 86 | 86G/0B | $0.0776 | -0.18% | 42↑ 41↓of 83 | — | — |
| Bausch & Lomb Incorporated | 86 | 55G/31B | $21.5114 | -0.73% | 22↑ 37↓of 59 | 1 | 8 |
| Topco Associates LLC | 86 | 86G/0B | $0.3786 | — | — | 3 | 2 |
| Breckenridge Pharmaceutical Inc. | 85 | 85G/0B | $1.7859 | +0.24% | 45↑ 35↓of 80 | — | — |
| E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 82 | 82G/0B | $0.5882 | +0.63% | 37↑ 21↓of 58 | — | — |
| Oxford Pharmaceuticals, LLC | 82 | 82G/0B | $0.0745 | +0.21% | 39↑ 43↓of 82 | — | — |
| Takeda Pharmaceuticals America, Inc. | 80 | 1G/79B | $29.7675 | -0.01% | 11↑ 30↓of 41 | — | 14 |
| Mayne Pharma | 78 | 65G/13B | $33.5529 | +0.06% | 13↑ 22↓of 35 | 3 | 6 |
| Sagent Pharmaceuticals | 78 | 78G/0B | $6.5283 | -0.25% | 18↑ 24↓of 42 | — | — |
| Eli Lilly and Company | 77 | 4G/73B | $630.19 | -0.01% | 20↑ 25↓of 45 | — | 4 |
| Modavar Pharmaceuticals LLC | 75 | 75G/0B | $0.1447 | +1.02% | 49↑ 26↓of 75 | — | — |
| Boehringer Ingelheim Pharmaceuticals Inc. | 73 | 1G/72B | $69.7029 | — | 19↑ 43↓of 62 | — | 3 |
| Janssen Pharmaceuticals Inc. | 70 | 0G/70B | $580.19 | -0.02% | 17↑ 33↓of 50 | — | 5 |
| Padagis US LLC | 70 | 68G/2B | $7.3173 | -1.60% | 23↑ 35↓of 58 | — | 6 |
| Legacy Pharmaceutical Packaging, LLC | 68 | 68G/0B | $0.0446 | +0.09% | 32↑ 36↓of 68 | 3 | 2 |
| AstraZeneca Pharmaceuticals LP | 67 | 2G/65B | $38.4931 | -0.04% | 10↑ 22↓of 32 | — | 6 |
| GlaxoSmithKline LLC | 67 | 0G/67B | $34.5764 | — | 11↑ 28↓of 39 | — | 6 |
| Eugia US LLC | 67 | 67G/0B | $12.6054 | +2.72% | 19↑ 18↓of 37 | 1 | 1 |
| Meitheal Pharmaceuticals Inc. | 63 | 62G/1B | $22.6209 | -0.71% | 16↑ 22↓of 38 | — | — |
| Organon LLC | 62 | 1G/61B | $76.3920 | +0.04% | 18↑ 14↓of 32 | — | 14 |
| PAI Holdings LLC | 60 | 60G/0B | $4.2618 | -2.07% | 18↑ 26↓of 44 | 3 | 3 |
| PuraCap Laboratories LLC | 59 | 59G/0B | $0.6517 | -0.19% | 26↑ 25↓of 51 | 1 | — |
| Carlsbad Technology Inc. | 56 | 56G/0B | $0.1096 | +3.32% | 37↑ 10↓of 47 | — | — |
| Camber Consumer Care | 56 | 56G/0B | $0.1570 | -0.11% | 24↑ 27↓of 51 | — | — |
| Cranbury Pharmaceuticals, LLC | 56 | 56G/0B | $0.1676 | -1.13% | 22↑ 30↓of 52 | 1 | 1 |
| Novo Nordisk | 55 | 8G/47B | $181.78 | -0.03% | 7↑ 23↓of 30 | — | 1 |
| Pharmacia & Upjohn Company LLC | 55 | 0G/55B | $25.2676 | -0.28% | 6↑ 10↓of 16 | — | 9 |
| Sanofi-Aventis U.S. LLC | 54 | 17G/37B | $200.30 | +0.24% | 11↑ 21↓of 32 | 1 | 6 |
| Eywa Pharma Inc | 51 | 51G/0B | $0.4101 | -1.70% | 9↑ 26↓of 35 | — | — |
| McKesson | 50 | 50G/0B | $0.2582 | -0.73% | 6↑ 10↓of 16 | 2 | 1 |
| Laurus Labs Limited | 50 | 50G/0B | $0.3382 | -0.34% | 15↑ 30↓of 45 | — | — |
| Precision Dose Inc. | 48 | 48G/0B | $0.3692 | -0.44% | 19↑ 25↓of 44 | 1 | 1 |
| Alcon Laboratories, Inc. | 48 | 4G/44B | $12.0474 | -0.56% | 19↑ 16↓of 35 | — | 3 |
| Acella Pharmaceuticals, LLC | 48 | 48G/0B | $1.0405 | -0.05% | 25↑ 12↓of 37 | — | 2 |
| Florida Pharmaceutical Products, LLC | 48 | 48G/0B | $1.1283 | +4.16% | 26↑ 6↓of 32 | — | 1 |
| Bayer HealthCare LLC | 47 | 0G/47B | $0.5913 | — | — | — | 3 |
| Edenbridge Pharmaceuticals LLC | 46 | 46G/0B | $0.8346 | +0.56% | 19↑ 23↓of 42 | — | 1 |
| Elite Laboratories, Inc. | 46 | 46G/0B | $0.7812 | -0.23% | 19↑ 27↓of 46 | — | — |
| Trigen Laboratories, LLC | 45 | 45G/0B | $3.7170 | +2.33% | 23↑ 19↓of 42 | 1 | 2 |
| Quagen Pharmaceuticals LLC | 44 | 44G/0B | $0.3203 | +0.87% | 24↑ 18↓of 42 | — | — |
| Wilshire Pharmaceuticals Inc. | 42 | 42G/0B | $2.4659 | -0.34% | 19↑ 20↓of 39 | — | 1 |
| Par Health USA, LLC | 42 | 39G/3B | $3.6904 | -0.58% | 14↑ 18↓of 32 | — | 1 |
| Ohm Laboratories Inc. | 40 | 40G/0B | $0.2522 | +0.29% | 15↑ 18↓of 33 | — | 1 |
| Winder Laboratories LLC | 40 | 40G/0B | $0.9654 | -0.22% | 23↑ 14↓of 37 | — | — |
| Apnar Pharma LP | 37 | 37G/0B | $0.1409 | +1.22% | 21↑ 13↓of 34 | — | — |
| Mullan Pharmaceutical Inc. | 37 | 37G/0B | $1.6337 | +0.30% | 21↑ 15↓of 36 | — | — |
| UCB, Inc. | 37 | 0G/37B | $1007.31 | — | 13↑ 18↓of 31 | — | 3 |
| Sunrise Pharmaceutical Inc. | 37 | 37G/0B | $0.1821 | -0.30% | 14↑ 20↓of 34 | — | 1 |
| ACI Healthcare USA, Inc. | 36 | 36G/0B | $0.0611 | -0.10% | 10↑ 7↓of 17 | — | — |
| Baxter Healthcare Corporation | 35 | 35G/0B | $8.2547 | +1.15% | 10↑ 3↓of 13 | 1 | 1 |
| Vitruvias Therapeutics Inc. | 34 | 34G/0B | $2.1737 | +2.47% | 21↑ 10↓of 31 | — | — |
| Azurity Pharmaceuticals Inc. | 34 | 1G/33B | $5.7887 | +0.02% | 4↑ 9↓of 13 | 1 | 8 |
| Burel Pharmaceuticals, LLC | 33 | 33G/0B | $0.5826 | +1.75% | 16↑ 13↓of 29 | 1 | — |
| Amici Pharmaceuticals LLC | 32 | 32G/0B | $0.7139 | -0.76% | 16↑ 15↓of 31 | — | — |
| Amgen Inc. | 32 | 0G/32B | $875.27 | — | 8↑ 2↓of 10 | — | 1 |
| IBSA Pharma Inc. | 31 | 0G/31B | $5.3518 | — | — | — | 1 |
| Ritedose Pharmaceuticals, LLC | 30 | 30G/0B | $0.3196 | -0.75% | 10↑ 20↓of 30 | — | — |
| Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 30 | 0G/30B | $10.5317 | -0.06% | 3↑ 19↓of 22 | — | 3 |
| TAGI Pharma Inc. | 29 | 29G/0B | $0.2435 | — | — | 1 | 1 |
| Civica, Inc. | 28 | 28G/0B | $3.6211 | -0.39% | 9↑ 8↓of 17 | — | — |
| Bayer HealthCare Pharmaceuticals Inc. | 28 | 0G/28B | $45.3794 | -0.02% | 9↑ 15↓of 24 | — | 1 |
| Otsuka America Pharmaceutical Inc. | 27 | 0G/27B | $721.70 | +0.03% | 11↑ 7↓of 18 | — | 2 |
| Novitium Pharma LLC | 27 | 27G/0B | $0.5055 | +0.70% | 11↑ 15↓of 26 | — | 1 |
| SOLA Pharmaceuticals LLC | 26 | 26G/0B | $0.9740 | -2.17% | 7↑ 18↓of 25 | — | — |
| Atlantis Consumer Healthcare, Inc. | 26 | 3G/23B | $0.2196 | +0.19% | 13↑ 7↓of 20 | — | 1 |
| Sigmapharm Laboratories LLC | 26 | 26G/0B | $3.0470 | -0.70% | 11↑ 13↓of 24 | 1 | — |
| Purdue Pharma LP | 25 | 0G/25B | $35.5925 | -0.01% | 11↑ 9↓of 20 | — | 1 |
| Galderma Laboratories, L.P. | 25 | 0G/25B | $11.4615 | +0.03% | 3↑ 1↓of 4 | — | 7 |
| Nephron Pharmaceuticals Corporation | 24 | 23G/1B | $0.2434 | -1.62% | 4↑ 15↓of 19 | — | — |
| Fosun Pharma USA Inc. | 24 | 24G/0B | $8.2562 | +2.52% | 13↑ 5↓of 18 | — | — |
| Ipca Laboratories Limited | 24 | 24G/0B | $0.0732 | -1.62% | 8↑ 16↓of 24 | — | — |
| Pacific Pharma, Inc. | 24 | 24G/0B | $5.3387 | -1.77% | 10↑ 10↓of 20 | — | 1 |
| E.R. Squibb & Sons, L.L.C. | 24 | 0G/24B | $177.86 | -0.03% | 8↑ 7↓of 15 | — | 3 |
| Noven Therapeutics, LLC | 23 | 5G/18B | $17.3115 | -0.16% | 6↑ 7↓of 13 | — | — |
| H2-Pharma LLC | 22 | 10G/12B | $25.2940 | +1.09% | 7↑ 8↓of 15 | 1 | 2 |
| Caplin Steriles Limited | 22 | 22G/0B | $2.6952 | -0.92% | 8↑ 10↓of 18 | — | 1 |
| Genus Lifesciences Inc. | 22 | 19G/3B | $1.5383 | +1.47% | 13↑ 2↓of 15 | — | 3 |
| Aarna USA Inc. | 21 | 21G/0B | $0.1238 | +0.13% | 8↑ 13↓of 21 | — | — |
| Almatica Pharma LLC | 21 | 7G/14B | $10.5792 | -0.84% | 7↑ 6↓of 13 | — | 8 |
| Devatis Inc. | 20 | 20G/0B | $5.2643 | -1.54% | 4↑ 7↓of 11 | — | — |
| American Regent, Inc. | 20 | 17G/3B | $8.7320 | +0.92% | 9↑ 3↓of 12 | — | 2 |
| WG Critical Care, LLC | 19 | 19G/0B | $6.7866 | +0.64% | 5↑ 2↓of 7 | — | 1 |
| Amphastar Pharmaceuticals, Inc. | 19 | 17G/2B | $76.9118 | -0.12% | 7↑ 8↓of 15 | — | — |
| Yiling Pharmaceutical Inc. | 19 | 19G/0B | $0.1560 | — | — | — | — |
| The Procter & Gamble Manufacturing Company | 18 | 0G/18B | $0.2947 | — | — | — | — |
| Astellas Pharma US, Inc. | 18 | 0G/18B | $17.5146 | -0.04% | 3↑ 9↓of 12 | — | 2 |
| Gilead Sciences, Inc. | 18 | 0G/18B | $286.48 | — | 3↑ 4↓of 7 | — | 2 |
| Oryza Pharmaceuticals Inc. | 18 | 18G/0B | $0.1351 | +7.91% | 14↑ 4↓of 18 | — | — |
| Neolpharma, Inc. | 17 | 17G/0B | $0.0574 | +2.40% | 16↑ 1↓of 17 | — | — |
| Reliable 1 Laboratories LLC | 17 | 17G/0B | $0.0268 | — | — | — | — |
| Vertical Pharmaceuticals, LLC | 17 | 3G/14B | $8.2753 | +0.04% | 4↑ 3↓of 7 | — | 2 |
| Amici Pharma, Inc | 16 | 16G/0B | $0.4352 | +1.10% | 8↑ 8↓of 16 | — | — |
| Tris Pharma Inc | 16 | 16G/0B | $0.3813 | +6.20% | 6↑ 0↓of 6 | — | 1 |
| Teva Neuroscience, Inc. | 16 | 0G/16B | $244.51 | -0.01% | 5↑ 7↓of 12 | — | 1 |
| Vensun Pharmaceuticals, Inc. | 15 | 15G/0B | $0.0549 | — | — | — | — |
| Seton Pharmaceuticals | 15 | 15G/0B | $21.3656 | — | — | — | — |
| Sumitomo Pharma America, Inc. | 15 | 0G/15B | $42.3863 | +0.07% | 4↑ 3↓of 7 | — | 2 |
| e5 Pharma, LLC | 15 | 15G/0B | $0.5796 | -0.40% | 9↑ 6↓of 15 | — | — |
| Eisai Inc. | 15 | 0G/15B | $22.0829 | -0.01% | 2↑ 7↓of 9 | — | 2 |
| Xellia Pharmaceuticals USA LLC | 15 | 15G/0B | $12.0994 | -4.14% | 2↑ 2↓of 4 | — | — |
| Genentech, Inc. | 15 | 0G/15B | $196.51 | -0.11% | 0↑ 5↓of 5 | — | 2 |
| Bausch & Lomb Americas Inc. | 15 | 15G/0B | $12.5048 | -0.81% | 6↑ 9↓of 15 | — | 1 |
| B. Braun Medical Inc. | 15 | 15G/0B | $0.0047 | +4.22% | 3↑ 0↓of 3 | — | — |
| Natco Pharma USA LLC | 15 | 15G/0B | $0.3056 | -1.81% | 4↑ 9↓of 13 | — | — |
| Neos Therapeutics Brands, LLC | 15 | 6G/9B | $16.4630 | -0.64% | 1↑ 14↓of 15 | — | 1 |
| Armas Pharmaceuticals Inc. | 15 | 15G/0B | $1.5874 | -0.57% | 3↑ 4↓of 7 | 1 | 1 |
| Trifluent Pharma LLC | 15 | 15G/0B | $5.8810 | -0.20% | 8↑ 5↓of 13 | — | 2 |
| Salix Pharmaceuticals Inc. | 15 | 0G/15B | $105.14 | — | — | — | 1 |
| Supernus Pharmaceuticals Inc. | 15 | 0G/15B | $20.4797 | -0.02% | 3↑ 2↓of 5 | — | 2 |
| Solaris Pharma Corporation | 14 | 14G/0B | $2.0966 | +0.68% | 10↑ 4↓of 14 | — | — |
| Xttrium Laboratories, Inc. | 14 | 10G/4B | $0.0430 | -0.24% | 4↑ 8↓of 12 | — | — |
| YARAL Pharma Inc. | 14 | 14G/0B | $2.6555 | — | — | — | — |
| Archis Pharma LLC | 14 | 14G/0B | $0.7336 | +1.38% | 6↑ 3↓of 9 | — | 1 |
| Saptalis Pharmaceuticals LLC | 13 | 11G/2B | $0.9993 | +0.12% | 9↑ 4↓of 13 | — | 1 |
| Provell Pharmaceuticals, LLC | 13 | 0G/13B | $0.1719 | — | — | — | — |
| Janssen Products LP | 13 | 0G/13B | $190.36 | -0.08% | 1↑ 3↓of 4 | — | 2 |
| Llorens Pharmaceutical International Division | 13 | 13G/0B | $0.0982 | -1.62% | 2↑ 6↓of 8 | — | — |
| BE Pharmaceuticals Inc. | 13 | 13G/0B | $10.4636 | -0.69% | 3↑ 6↓of 9 | — | — |
| ViiV Healthcare Company | 13 | 0G/13B | $60.6386 | +0.02% | 6↑ 0↓of 6 | — | 3 |
| NextWave Pharmaceuticals, Inc | 13 | 0G/13B | $8.9278 | — | 6↑ 6↓of 12 | — | 1 |
| Pharbest Pharmaceuticals, Inc. | 13 | 13G/0B | $0.0255 | — | — | — | — |
| Innogenix, Inc. | 13 | 13G/0B | $0.1626 | — | — | — | — |
| USAntibiotics, LLC | 13 | 13G/0B | $0.1804 | +1.40% | 4↑ 9↓of 13 | — | — |
| Collegium Pharmaceutical, Inc. | 13 | 0G/13B | $17.5109 | — | — | — | — |
| Afaxys Pharma, LLC | 13 | 13G/0B | $0.6154 | -0.29% | 5↑ 8↓of 13 | — | — |
| Patrin Pharma Inc. | 12 | 12G/0B | $0.4829 | +1.05% | 6↑ 4↓of 10 | 1 | 1 |
| Mission Pharmacal Company | 12 | 2G/10B | $4.3292 | -0.47% | 1↑ 1↓of 2 | — | 3 |
| Nordic Pharma, Inc. | 12 | 12G/0B | $5.3275 | -0.29% | 5↑ 7↓of 12 | — | — |
| i3 Pharmaceuticals, LLC | 12 | 12G/0B | $1.8376 | +1.36% | 7↑ 5↓of 12 | — | — |
| Roerig | 12 | 0G/12B | $23.0862 | — | — | — | 3 |
| Poly Pharmaceuticals, Inc. | 11 | 11G/0B | $0.5260 | -0.03% | 1↑ 1↓of 2 | — | — |
| C.B. Fleet Company, Inc. | 11 | 0G/11B | $0.1010 | -0.26% | 0↑ 1↓of 1 | — | 2 |
| Zameer Pharmaceuticals LLC | 11 | 11G/0B | $0.7014 | +2.97% | 1↑ 0↓of 1 | — | 3 |
| Crown Laboratories | 11 | 9G/2B | $0.2542 | — | — | — | 1 |
| CarWin Pharmaceutical Associates LLC | 11 | 2G/9B | $14.7097 | -2.63% | 0↑ 2↓of 2 | — | 3 |
| Larken Laboratories, Inc. | 11 | 11G/0B | $0.2038 | +0.09% | 3↑ 3↓of 6 | — | — |
| Edwards Pharmaceuticals, Inc. | 11 | 10G/1B | $0.8324 | +1.67% | 3↑ 1↓of 4 | — | — |
| Arbor Pharmaceuticals, Inc. | 11 | 11G/0B | $3.6347 | +1.06% | 2↑ 2↓of 4 | — | — |
| Novugen Pharma (USA) LLC | 11 | 11G/0B | $0.6417 | +0.34% | 5↑ 6↓of 11 | — | — |
| TWi Pharmaceuticals, Inc. | 11 | 11G/0B | $0.1389 | +0.01% | 1↑ 2↓of 3 | 1 | — |
| Aimmune Therapeutics, Inc. | 10 | 0G/10B | $8.5834 | +0.02% | 2↑ 4↓of 6 | — | — |
| Cambridge Therapeutics Technologies, LLC | 10 | 10G/0B | $0.2930 | — | — | — | 1 |
| Teva Parenteral Medicines, Inc. | 10 | 10G/0B | $2.8602 | -0.27% | 2↑ 2↓of 4 | — | 1 |
| Exeltis USA, Inc. | 10 | 0G/10B | $7.7829 | +0.08% | 4↑ 4↓of 8 | — | 1 |
| VistaPharm, LLC | 10 | 10G/0B | $0.7319 | -2.25% | 2↑ 6↓of 8 | — | 1 |
| Alkermes, Inc. | 10 | 0G/10B | $697.72 | +0.02% | 6↑ 2↓of 8 | — | — |
| Currax Pharmaceuticals LLC | 10 | 3G/7B | $24.6196 | — | — | — | 1 |
| Janssen Biotech, Inc. | 10 | 0G/10B | $13095.66 | -0.07% | 1↑ 2↓of 3 | — | 1 |
| CivicaScript LLC | 10 | 10G/0B | $0.6906 | -1.64% | 3↑ 6↓of 9 | — | — |
| SK Life Science, Inc. | 10 | 0G/10B | $35.3012 | +0.03% | 5↑ 2↓of 7 | — | — |
| Hepalink USA Inc. | 10 | 10G/0B | $6.7829 | +0.74% | 4↑ 5↓of 9 | — | — |
| Sheffield Pharmaceuticals LLC | 10 | 10G/0B | $0.1002 | +0.22% | 7↑ 3↓of 10 | — | — |
| EMD Serono, Inc. | 9 | 0G/9B | $1429.39 | +0.02% | 1↑ 0↓of 1 | — | — |
| Apozeal Pharmaceuticals Inc. | 9 | 9G/0B | $0.0340 | -5.71% | 2↑ 7↓of 9 | — | — |
| Axsome Therapeutics, Inc. | 9 | 0G/9B | $38.1276 | -0.01% | 2↑ 3↓of 5 | — | — |
| Carnegie Pharmaceuticals LLC | 9 | 7G/2B | $1.2931 | +0.24% | 4↑ 3↓of 7 | — | — |
| International Medication Systems, Limited | 9 | 9G/0B | $3.8399 | -6.97% | 3↑ 3↓of 6 | — | 1 |
| Virtus Pharmaceuticals, LLC | 9 | 9G/0B | $2.1776 | -0.72% | 0↑ 1↓of 1 | 1 | 2 |
| Person and Covey | 9 | 4G/5B | $0.0987 | +0.19% | 2↑ 0↓of 2 | — | — |
| XGen Pharmaceuticals DJB, Inc. | 9 | 9G/0B | $10.0547 | -0.80% | 2↑ 3↓of 5 | — | — |
| Nomax Inc. | 9 | 9G/0B | $0.4212 | +0.99% | 9↑ 0↓of 9 | — | — |
| Antares Pharma, Inc. | 9 | 0G/9B | $325.25 | -0.02% | 3↑ 1↓of 4 | — | 1 |
| Avet Pharmaceuticals Inc. | 9 | 9G/0B | $0.9958 | +3.18% | 7↑ 2↓of 9 | — | — |
| CMP Pharma, Inc. | 9 | 5G/4B | $2.5328 | +0.49% | 3↑ 1↓of 4 | 1 | 1 |
| Avion Pharmaceuticals, LLC | 9 | 0G/9B | $8.4222 | +0.09% | 2↑ 0↓of 2 | — | 1 |
| ARMAS PHARMACEUTICALS INC. | 9 | 9G/0B | $8.6410 | -2.68% | 2↑ 7↓of 9 | — | 1 |
| Gabar Health Sciences Corp. | 8 | 8G/0B | $0.2666 | — | — | 1 | 1 |
| Medimetriks Pharmaceuticals Inc. | 8 | 4G/4B | $40.7872 | +2.53% | 3↑ 1↓of 4 | — | 4 |
| Cephalon, LLC | 8 | 0G/8B | $47.2468 | +0.06% | 2↑ 0↓of 2 | — | 2 |
| Neurelis, Inc | 8 | 0G/8B | $366.04 | -0.02% | 1↑ 2↓of 3 | — | — |
| Avenacy Inc. | 8 | 8G/0B | $29.9486 | -0.42% | 2↑ 3↓of 5 | — | — |
| BioDelivery Sciences International Inc | 8 | 0G/8B | $14.1467 | — | 3↑ 4↓of 7 | — | — |
| Omnivium Pharmaceuticals LLC | 8 | 8G/0B | $1.6677 | -1.87% | 3↑ 2↓of 5 | — | 2 |
| Harrow Eye, LLC | 8 | 0G/8B | $91.3032 | -0.06% | 0↑ 4↓of 4 | — | 2 |
| Validus Pharmaceuticals LLC | 8 | 0G/8B | $2.5597 | -0.06% | 1↑ 3↓of 4 | — | 3 |
| Ferring Pharmaceuticals Inc. | 8 | 1G/7B | $167.36 | -0.23% | 1↑ 1↓of 2 | — | 1 |
| Teva Respiratory, LLC | 8 | 0G/8B | $131.26 | +0.07% | 3↑ 2↓of 5 | — | 2 |
| Medexus Pharma Inc. | 7 | 0G/7B | $541.12 | +0.02% | 1↑ 2↓of 3 | — | 1 |
| Fougera Pharmaceuticals Inc. | 7 | 7G/0B | $2.0295 | +3.90% | 4↑ 1↓of 5 | — | — |
| Catalyst Pharmaceuticals, Inc. | 7 | 0G/7B | $31.3768 | -0.03% | 1↑ 5↓of 6 | — | — |
| Indivior Inc. | 7 | 0G/7B | $705.30 | -0.04% | 1↑ 3↓of 4 | — | 1 |
| OWP Pharmaceuticals, Inc. | 7 | 7G/0B | $4.1555 | +0.67% | 3↑ 2↓of 5 | — | 1 |
| Daiichi Sankyo Inc. | 7 | 0G/7B | $14.6260 | — | — | — | 1 |
| Advanz Pharma (US) Corp. | 7 | 0G/7B | $12.8504 | — | — | — | 3 |
| U.S. Pharmaceutical Corporation | 7 | 0G/7B | $0.7815 | +10.01% | 5↑ 0↓of 5 | — | — |
| Sebela Pharmaceuticals Inc. | 7 | 0G/7B | $21.1074 | — | — | — | 1 |
| Santarus Inc. | 7 | 0G/7B | $81.9991 | — | — | — | 3 |
| Vanda Pharmaceuticals Inc. | 7 | 0G/7B | $40.9490 | -0.15% | 0↑ 6↓of 6 | — | — |
| Digestive Care, Inc. | 6 | 0G/6B | $5.3491 | +0.14% | 2↑ 0↓of 2 | — | — |
| Melinta Therapeutics, LLC | 6 | 0G/6B | $25.4660 | — | — | — | 1 |
| Mannkind Corporation | 6 | 0G/6B | $10.3901 | +0.12% | 2↑ 1↓of 3 | — | — |
| PureTek Corporation | 6 | 6G/0B | $0.8987 | +1.24% | 1↑ 0↓of 1 | — | — |
| Foundation Consumer Healthcare LLC | 6 | 4G/2B | $14.6070 | — | — | — | 1 |
| Thea Pharma Inc. | 6 | 0G/6B | $29.0965 | -0.01% | 1↑ 4↓of 5 | — | 3 |
| Xeris Pharmaceuticals, Inc. | 6 | 0G/6B | $1868.41 | -0.10% | 1↑ 3↓of 4 | — | — |
| Hisun Pharmaceuticals USA Inc. | 6 | 6G/0B | $1.5594 | +1.39% | 3↑ 1↓of 4 | 1 | — |
| BioComp Pharma Inc. | 6 | 6G/0B | $1.0638 | +0.57% | 3↑ 2↓of 5 | — | — |
| Orexo US, Inc. | 6 | 0G/6B | $11.4076 | +0.02% | 4↑ 1↓of 5 | — | — |
| Vivus LLC | 6 | 0G/6B | $5.2303 | — | — | — | — |
| Kesin Pharma Corporation | 6 | 5G/1B | $0.6371 | -0.65% | 2↑ 2↓of 4 | — | — |
| Allegis Pharmaceuticals, LLC | 6 | 6G/0B | $6.8567 | +0.54% | 2↑ 2↓of 4 | — | — |
| INA Pharmaceutics Inc | 5 | 5G/0B | $7.8785 | -2.09% | 0↑ 3↓of 3 | — | 1 |
| Coloplast Manufacturing US, LLC | 5 | 4G/1B | $0.0663 | — | — | — | — |
| Covis Pharma US, Inc | 5 | 0G/5B | $27.5919 | -0.03% | 3↑ 2↓of 5 | — | 1 |
| Brookfield Pharmaceuticals, LLC | 5 | 5G/0B | $0.4933 | — | — | — | — |
| Hikma Specialty USA Inc. | 5 | 0G/5B | $17.1063 | +0.01% | 3↑ 1↓of 4 | — | 1 |
| Biocon Biologics Inc. | 5 | 2G/3B | $685.31 | -0.05% | 2↑ 1↓of 3 | — | — |
| Ironshore Pharmaceuticals Inc. | 5 | 0G/5B | $15.3968 | +0.02% | 3↑ 1↓of 4 | — | 1 |
| LEO Pharma Inc. | 5 | 0G/5B | $18.6736 | -0.02% | 1↑ 1↓of 2 | — | 2 |
| Leadiant Biosciences, Inc. | 5 | 0G/5B | $0.5517 | — | — | — | — |
| Oliva Therapeutics, LLC | 5 | 4G/1B | $0.3774 | -4.02% | 0↑ 5↓of 5 | — | — |
| Patriot Pharmaceuticals | 5 | 5G/0B | $13.6521 | -5.91% | 0↑ 2↓of 2 | — | 1 |
| Pharmaceutical Associates, Inc. | 5 | 5G/0B | $0.1824 | -1.38% | 1↑ 1↓of 2 | — | — |
| Provepharm Inc. | 5 | 5G/0B | $24.9874 | -1.62% | 0↑ 2↓of 2 | — | — |
| Rising Health, LLC | 5 | 5G/0B | $0.0811 | -0.98% | 2↑ 3↓of 5 | — | — |
| The J. Molner Company LLC | 5 | 5G/0B | $0.6453 | -0.02% | 2↑ 2↓of 4 | — | — |
| VGYAAN Pharmaceuticals LLC | 5 | 5G/0B | $52.5722 | — | — | — | 2 |
| Immunex Corporation | 4 | 0G/4B | $2082.25 | -0.02% | 1↑ 2↓of 3 | — | — |
| Hillestad Pharmaceuticals USA | 4 | 4G/0B | $0.2427 | +0.15% | 1↑ 1↓of 2 | — | — |
| Oncor Pharmaceuticals | 4 | 4G/0B | $0.1407 | +0.08% | 1↑ 3↓of 4 | — | — |
| Acertis Pharmaceuticals, LLC | 4 | 2G/2B | $16.5280 | -2.42% | 1↑ 3↓of 4 | — | 2 |
| Braintree Laboratories, Inc. | 4 | 0G/4B | $17.1490 | +0.04% | 3↑ 0↓of 3 | — | — |
| Aprecia Pharmaceuticals, LLC | 4 | 0G/4B | $10.2726 | — | — | — | 1 |
| Medicure International Inc | 4 | 0G/4B | $7.4073 | — | — | — | — |
| GenBioPro, Inc. | 4 | 4G/0B | $0.6937 | +0.30% | 3↑ 0↓of 3 | — | — |
| Quinn Pharmaceuticals | 4 | 4G/0B | $0.1586 | -0.34% | 2↑ 2↓of 4 | — | — |
| GM Pharmaceuticals, INC | 4 | 1G/3B | $0.1852 | — | — | — | — |
| Fresenius Kabi, LLC | 4 | 4G/0B | $4.4165 | — | — | — | — |
| Phathom Pharmaceuticals Inc. | 4 | 0G/4B | $14.9544 | -0.06% | 1↑ 2↓of 3 | — | — |
| TOLMAR Inc. | 4 | 1G/3B | $8.9875 | -0.01% | 3↑ 1↓of 4 | — | — |
| Vista Pharmaceuticals, Inc. | 4 | 4G/0B | $0.0788 | — | — | — | 1 |
| Duchesnay USA, Inc. | 4 | 0G/4B | $7.2758 | -0.09% | 0↑ 3↓of 3 | — | 1 |
| Cameron Pharmaceuticals | 4 | 4G/0B | $1.3966 | -0.50% | 2↑ 2↓of 4 | — | — |
| Dista Products Company | 4 | 0G/4B | $16.4383 | — | — | — | 1 |
| Beach Products, Inc. | 4 | 4G/0B | $0.5646 | +7.08% | 2↑ 2↓of 4 | — | — |
| ACI Healthcare USA Inc. | 4 | 4G/0B | $0.0362 | -2.02% | 0↑ 2↓of 2 | — | — |
| SDA Laboratories, Inc. | 4 | 4G/0B | $0.0285 | — | — | — | — |
| Marnel Pharmaceuticals, Inc. | 3 | 3G/0B | $2.2079 | — | — | — | — |
| BF ASCHER AND CO INC | 3 | 1G/2B | $0.0589 | — | — | — | — |
| Lundbeck Pharmaceuticals LLC | 3 | 0G/3B | $34.0644 | +0.03% | 3↑ 0↓of 3 | — | 1 |
| Long Grove Pharmaceuticals, LLC | 3 | 3G/0B | $5.4842 | +1.89% | 2↑ 1↓of 3 | — | — |
| Vifor Pharma, Inc. | 3 | 0G/3B | $37.8163 | -0.01% | 1↑ 2↓of 3 | — | — |
| Lifsa Drugs LLC | 3 | 3G/0B | $9.8841 | — | — | — | 1 |
| Lexicon Pharmaceuticals, Inc. | 3 | 0G/3B | $20.1047 | -0.45% | 0↑ 2↓of 2 | — | — |
| Laser Pharmaceuticals, LLC | 3 | 3G/0B | $1.0092 | — | — | — | 1 |
| Intra-Cellular Therapies, Inc | 3 | 0G/3B | $57.2228 | +0.01% | 1↑ 1↓of 2 | — | — |
| WOMENS CHOICE PHARMACEUTICALS LLC | 3 | 1G/2B | $3.1567 | — | — | — | — |
| West-Ward Pharmaceuticals Corp | 3 | 3G/0B | $0.2997 | — | — | — | 1 |
| Greenstone LLC | 3 | 3G/0B | $0.9218 | -2.50% | 0↑ 2↓of 2 | — | — |
| Genzyme Corporation | 3 | 0G/3B | $13.3447 | — | — | — | 1 |
| GRIFOLS USA, LLC | 3 | 0G/3B | $3.5465 | — | — | — | — |
| ALK-Abello A S | 3 | 0G/3B | $11.7327 | +0.01% | 2↑ 1↓of 3 | — | — |
| CIMA LABS INC. | 3 | 3G/0B | $0.3192 | -1.07% | 1↑ 1↓of 2 | — | — |
| Cumberland Pharmaceuticals Inc. | 3 | 0G/3B | $235.38 | — | — | — | — |
| Savage Laboratories a division of Fougera Pharmaceuticals Inc. | 3 | 0G/3B | $1.6286 | +0.04% | 2↑ 0↓of 2 | — | — |
| CDMA | 3 | 3G/0B | $0.0134 | -0.99% | 0↑ 2↓of 2 | — | — |
| Royal Pharmaceuticals | 3 | 0G/3B | $0.5382 | +0.01% | 1↑ 2↓of 3 | — | — |
| RedHill Biopharma Ltd | 3 | 0G/3B | $11.3557 | -0.01% | 0↑ 1↓of 1 | — | — |
| Aquestive Therapeutics | 3 | 0G/3B | $38.1888 | — | — | — | 1 |
| Affordable Pharmaceuticals, LLC | 3 | 3G/0B | $0.0315 | -0.76% | 2↑ 1↓of 3 | — | — |
| Quest Products, LLC | 3 | 0G/3B | $0.3819 | -0.07% | 1↑ 2↓of 3 | — | 1 |
| Teva Women's Health, Inc. | 3 | 0G/3B | $36.1484 | — | — | — | 1 |
| Capital Pharma | 3 | 0G/3B | $0.2383 | — | — | — | — |
| Puro Pharma Inc. | 3 | 3G/0B | $0.7339 | +3.27% | 2↑ 1↓of 3 | — | 1 |
| Piramal Critical Care | 3 | 3G/0B | $1.4663 | +3.24% | 1↑ 0↓of 1 | — | — |
| kaleo, Inc | 3 | 0G/3B | $308.35 | — | — | — | — |
| Phlow Corporation | 3 | 3G/0B | $0.5247 | -1.33% | 1↑ 1↓of 2 | — | — |
| Arcutis Biotherapeutics, Inc. | 3 | 0G/3B | $15.3811 | -0.06% | 0↑ 2↓of 2 | — | 1 |
| OPKO Pharmaceuticals LLC | 3 | 0G/3B | $40.4236 | -0.01% | 0↑ 1↓of 1 | — | — |
| Aucta Pharmaceuticals, Inc. | 3 | 0G/3B | $21.5376 | — | — | — | 1 |
| Neurocrine Biosciences, Inc. | 3 | 0G/3B | $284.74 | +3.50% | 3↑ 0↓of 3 | — | — |
| Millicent US, Inc. | 3 | 0G/3B | $601.40 | +0.07% | 3↑ 0↓of 3 | — | — |
| Adare Pharmaceuticals Inc | 3 | 3G/0B | $0.1265 | — | — | — | — |
| Corium, LLC. | 3 | 0G/3B | $14.4052 | -0.02% | 0↑ 3↓of 3 | — | — |
| Valinor Pharma, LLC | 3 | 0G/3B | $14.5979 | +0.05% | 2↑ 1↓of 3 | — | — |